Gene · 6652
Papers2,028
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,028
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathomechanisms of Diabetic Kidney Disease. | J Clin Med | 2023 | 38068400 | PubTator, text mining | PubMed |
| Complementary Approaches to Retinal Health Focusing on Diabetic Retinopathy. | Cells | 2023 | 38067127 | PubTator, text mining | PubMed |
| Exploring potent aldose reductase inhibitors for anti-diabetic (anti-hyperglycemic) therapy: integrating structure-based drug design, and MMGBSA approaches. | Front Mol Biosci | 2023 | 38053577 | PubTator, text mining | PubMed |
| Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson's disease. | Front Neurosci | 2023 | 38027497 | PubTator, text mining | PubMed |
| Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs. | Front Endocrinol (Lausanne) | 2023 | 38027178 | PubTator, text mining | PubMed |
| Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes. | Sci Rep | 2023 | 38017020 | PubTator, text mining | PubMed |
| Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia. | Int J Mol Sci | 2023 | 38003671 | PubTator, text mining | PubMed |
| The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. | Basic Res Cardiol | 2023 | 37938421 | PubTator, text mining | PubMed |
| In Silico Studies, Anti-oxidant Properties, Antisorbitol Dehydrogenase, Anti-alpha Amylase and Anti-gastrointestinal Cancer Potential of Violanthin as a Natural Compound. | J Oleo Sci | 2023 | 37914263 | PubTator, text mining | PubMed |
| High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder. | Front Mol Neurosci | 2023 | 37908488 | PubTator, text mining | PubMed |
| The pathophysiology of diabetic foot: a narrative review. | J Yeungnam Med Sci | 2023 | 37797951 | PubTator, text mining | PubMed |
| Anti-lung Cancer, Anti-microbial, Anti-α-glucosidase, Anti-sorbitol Dehydrogenase, and in silico Studies of Wogonoside and Isoliquiritigenin as Natural Compounds. | J Oleo Sci | 2023 | 37793822 | PubTator, text mining | PubMed |
| Elevated Erythritol: A Marker of Metabolic Dysregulation or Contributor to the Pathogenesis of Cardiometabolic Disease? | Nutrients | 2023 | 37764794 | PubTator, text mining | PubMed |
| Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications. | J Clin Med | 2023 | 37762992 | PubTator, text mining | PubMed |
| Research progress on the pathogenesis of diabetic retinopathy. | BMC Ophthalmol | 2023 | 37697295 | PubTator, text mining | PubMed |
| Insight into the Molecular Mechanism of Diabetic Kidney Disease and the Role of Metformin in Its Pathogenesis. | Int J Mol Sci | 2023 | 37685845 | PubTator, text mining | PubMed |
| Sugar and Dyslipidemia: A Double-Hit, Perfect Storm. | J Clin Med | 2023 | 37685728 | PubTator, text mining | PubMed |
| Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer. | Cancer Discov | 2023 | 37676710 | PubTator, text mining | PubMed |
| Current status and progress in research on dressing management for diabetic foot ulcer. | Front Endocrinol (Lausanne) | 2023 | 37664860 | PubTator, text mining | PubMed |
| Decreased oocyte quality in patients with endometriosis is closely related to abnormal granulosa cells. | Front Endocrinol (Lausanne) | 2023 | 37664845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6652/papers?page=5